VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Friday, January 2, 2026
Stock Comparison
Novartis AG vs Wolters Kluwer N.V.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Novartis AG
NOVN · SIX Swiss Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novartis AG's moat claims, evidence, and risks.
View NOVN analysisWolters Kluwer N.V.
WKL · Euronext Amsterdam
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Wolters Kluwer N.V.'s moat claims, evidence, and risks.
View WKL analysisComparison highlights
- Moat score gap: Wolters Kluwer N.V. leads (73 / 100 vs 65 / 100 for Novartis AG).
- Segment focus: Novartis AG has 5 segments (29.3% in Oncology); Wolters Kluwer N.V. has 5 segments (26.8% in Health).
- Moat breadth: Novartis AG has 4 moat types across 3 domains; Wolters Kluwer N.V. has 6 across 2.
Primary market context
Novartis AG
Oncology
Oncology and hematology branded medicines (including targeted therapies and radioligand therapy)
Global
Oncologists and hospitals; reimbursed by payers; hospital and specialty pharmacy channels
Originator developer, manufacturer, and marketer of oncology therapies
29.3%
Wolters Kluwer N.V.
Health
Clinical decision support and clinical drug information solutions (point-of-care) for healthcare providers
Global
Hospitals/health systems, clinicians, payers, and academic institutions
Software + expert content provider
26.8%
Side-by-side metrics
Moat coverage
Shared moat types
Novartis AG strengths
Wolters Kluwer N.V. strengths
Segment mix
Novartis AG segments
Full profile >Cardiovascular, Renal and Metabolic
Oligopoly
Immunology
Oligopoly
Neuroscience
Oligopoly
Oncology
Oligopoly
Established Brands
Competitive
Wolters Kluwer N.V. segments
Full profile >Health
Oligopoly
Tax & Accounting
Oligopoly
Financial & Corporate Compliance
Oligopoly
Legal & Regulatory
Oligopoly
Corporate Performance & ESG
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.